6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...
30 April 2020 - European Commission decision was received six weeks earlier than expected. ...
25 April 2020 - CSL has been forced to defend the way it runs its blood plasma collection business in ...
21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...
8 April 2020 - It sounds like a pitch for a sci-fi thriller — using genetically modified cows to fight ...
6 April 2020 - Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the ...
1 April 2020 - The U.S. FDA today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding ...
28 January 2020 - Factor VIII drugs are used to treat a form of hemorrhagic disease, hemophilia A, which involves ...
5 November 2019 - Octapharma announced today that the human fibrinogen concentrate fibryga has received approval for use in treatment of ...
5 November 2019 - A severe shortage of immune globulin — a popular medicine used to treat epilepsy, cancer and ...
8 October 2019 - Octapharma USA today announced the U.S. FDA has approved Wilate for treatment of adults and adolescents with ...
27 July 2019 - Agency clarifies its position on controversial treatment made popular by superstar athletes. ...
12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...
8 July 2019 - All aspects of the Biotest Therapy Business Unit acquisition are successfully completed. ...
4 July 2019 - Xembify is Grifols’ first 20% subcutaneous immunoglobulin for the treatment of primary immunodeficiencies. ...